Funding which supports commercially viable innovation for implementation, adoption
Aim
Funding to support development of a clinically significant and commercially viable innovation to accelerate commercialization and eventual implementation and adoption of the innovation to impact and benefit healthcare delivery and patient care
Eligibility
The Principal Investigator must hold a primary appointment in and be under the employment of a public healthcare institution or academic medical school in Singapore.
- Considerations for project gearing toward clinical adoption:
-
- Commercial position: Interest to trial for eventual implementation and adoption cross cluster.
- Two or more clusters indicating interest to implement & adopt post-pilot (in Letter of Interest)
- Approved/Registered or close to regulatory approval or registration; ethics submission or approval (as applicable)
- Industry partner’s commitment to pilot and implement
Theme (Screening):
- To detect early onset of disease indicators
- Enhance proactive screening in homes, primary or community care settings
Funding criteria
Grant applications that emphasise on the following aspects of the project are considered for funding:
- Well defined unmet healthcare need
- Clear deployment and product development strategy/roadmap
- Potential to result in reduced healthcare costs, improved clinical outcome and eventual adoption by the healthcare system.
- Proven scientific merit with proof-of-concept data in in vitro and/or in vivo research/laboratory models
- Strong intellectual property position will have an advantage
Funding Quantum
Up to $1Mil^
^Quantum reviewed on a Project by Project basis
Funding Duration
12 months, Up to 18 months
Grant call opens
1 November 2022
Anticipated Time Line
Remarks |
Estimated dates |
|
1 | Grant Call Opens- submission of Letter of Intent from PHI | 1 Nov 2022 |
2 | Grant Call Closes | 3 Jan 2023 |
3 | Invite to full proposal | Feb 2023 |
4 | Evaluation | Apr 2023 |
5 | Funding Decision | May 2023 |
Grant Process
- All grant applications are evaluated based on the criteria detailed below.
- LOI template can be downloaded here
- Only shortlisted applicants will be invited to submit full proposal and pitch to the Evaluation Panel
- For further queries on this grant, please contact NHIC at This email address is being protected from spambots. You need JavaScript enabled to view it.
NHIC I2Adopt Evaluation Criteria Considerations
Category | Considerations |
Background & data |
|
Uniqueness of technology |
|
Implementation plan & deliverables |
|
Business Considerations |
|
Healthcare impact |
|
Team Composition |
|
Budget | Is the budget realistic for the work outlined? |
Upcoming I2Adopt Grant Calls
I2Adopt Cycle 2 on Diagnostics and Monitoring: Opens 3 April 2023, closes 2 May 2023
I2Adopt Cycle 3 on Intervention: Opens 4 Aug 2023, closes 4 Sept 2023
Frequently Asked Questions (FAQs)
Please refer to our list of FAQs for more information.